NextCure, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 74.73 million compared to USD 69.39 million a year ago. Basic loss per share from continuing operations was USD 2.69 compared to USD 2.51 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.58 USD | 0.00% | +30.58% | +38.60% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.60% | 44.2M | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- NXTC Stock
- News NextCure, Inc.
- NextCure, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022